Clinical Trials Logo

Clinical Trial Summary

Various parts of the brain are sensitive to various anesthetics.We like to study the effect of dexmedetomidine on the different parts of the brain in patients who are coming for DBS electrode removal under sedation.


Clinical Trial Description

Cortical and sub cortical structures will have different sensitivities to various anesthetics.The objective of this study is to look at the changes in the intracranial electroencephalographic (EEG) characteristics during dexmedetomidine sedation and to determine the differences in the EEG characteristics between cortical and subcortical structures. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01648959
Study type Observational
Source University Health Network, Toronto
Contact
Status Terminated
Phase
Start date July 2012
Completion date March 2014

See also
  Status Clinical Trial Phase
Completed NCT00425282 - A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. Phase 3
Completed NCT00433667 - A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. Phase 3
Completed NCT01749046 - Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures Phase 3
Completed NCT00991757 - An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures. Phase 3
Terminated NCT01266291 - Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) Patients Phase 4